Effect of Ellagic Acid, a Plant Polyphenol, on Fibrotic Markers (MMPs and TIMPs) during Alcohol-Induced Hepatotoxicity

REFERENCES

• Ahn D., Putt D., Kresty L., Stoner G. D., Fromm D., Hollenberg P. F. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis 1996; 17: 821–828
   PubMed Web of Science ®Google Scholar
• Ambili M., Pillai M. R., Sudhakaran P. R. Characteristics of 60 K gelatinase involved in rat mammary gland involution. Indian J. Biochem. Biophys. 1997; 34: 347–353
   PubMedGoogle Scholar
• Ambili M., Sudhakaran P. R. Assay of matrix metalloproteinases in substrate impregnated gels in multiwells. Indian J. Biochem. Biophys. 1998; 35: 317–320
   PubMedGoogle Scholar
• Arthur M. Jẋ P. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2000; 279: G245–249
   PubMed Web of Science ®Google Scholar
• Baragi V. M., Shaw B. J., Renkiewicz R. R., Kuipers P. J., Welgus H. G., Mathrubutham M., Cohen J. R., Rao S. K. A versatile assay for gelatinases using succinylated gelatin. Matrix Biol. 2000; 19: 267–273
   PubMedGoogle Scholar
• Bellosta S., Dell'Agli M., Canavesi M., Mitro N., Monetti M., Crestani M., Verotta L., Fuzzati N., Bernini F., Bosisio E. Inhibition of metallo-proteinase-9 activity and gene expression by polyphenolic compounds isolated from the bark of Tristaniopsis caloburus (Myrtaceae). Cell Mol. Life Sci. 2003; 60: 1440–1448
   Google Scholar
• Bissell D. M. Chronic liver injury; TGF-beta and cancer. Exp. Mol. Med. 2001; 33: 179–190
   PubMedGoogle Scholar
• Buniatian G. H. Stages of activation of hepatic stellate cells: effects of ellagic acid, an inhibiter of liver fibrosis, on their differentiation in culture. Cell Prolif. 2003; 36: 307–319
   PubMed Web of Science ®Google Scholar
• Denhardt D. T., Feng B., Edwards D. R., Cocuzzi E. T., Malyankar U. M. Tissue inhibitor of metalloproteinases (TIMP, aka EPA): structure, control of expression and biological functions. Pharmacol. Ther. 1993; 59: 329–341
   PubMed Web of Science ®Google Scholar
• Dooley S., Delvoux B., Streckert M., Bonzel L., Stopa M., tenDijke P., Gressner A. M. Transforming growth factor beta signal transduction in hepatic stellate cell via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGF-beta signal transduction during trans differentiation of hepatic stellate cells. FEBS Lett. 2001; 502: 4–10
   Google Scholar
• Giavazzi R., Taraboletti G. Preclinical development of metalloproteasis inhibitors in cancer therapy. Crit. Rev. Oncol. Hematol. 2001; 37: 53–60
   Google Scholar
• Herbst H., Heinrichs O., Schuppan D., Milani S., Stein H. Temporal and spatial patterns of trans/stromelysim RNA expression following toxic injury in rat liver. Virchows. Arch. 1991; 60: 295–300
   Google Scholar
• Herbst H., Wege T., Milani S., Pellegrini G., Orzechowski H. D., Bechestein W. O., Neuhaus P., Gressner A. M., Schuppan D. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am. J. Pathol. 1997; 150: 1647–1659
   PubMedGoogle Scholar
• Iredale J. P. Tissue inhibitors of metalloproteinases in liver fibrosis. Int. J. Biochem. Cell Biol. 1997; 29: 43–54
   PubMed Web of Science ®Google Scholar
• Itoh Y., Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J. Cell Physiol. 2006; 206: 1–8
   PubMed Web of Science ®Google Scholar
• Iype T., Jayasree K., Sudhakaran P. R. Modulation of alpha2beta1 integrin changes during mammary gland development by beta-oestradiol. Biochim. Biophys. Acta 2001; 1499: 232–241
   PubMedGoogle Scholar
• Jones M. K., Sasaki E., Halter F., Pai R., Nakamura T., Arakawa T., Kuroki T., Tarnawski A. S. HGF triggers activation of COX-2 gene in rat gastric epithelial cells: action mediated through the ERK2 signaling pathway. FASEB J. 1999; 13: 2186–2194
   Google Scholar
• Kwon S. H., Pimentel D. R., Remondino A., Sawyer D. B., Colucci W. S. H2 O2 regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. J. Mol. Cell. Cardiol. 2003; 35: 615–621
   PubMed Web of Science ®Google Scholar
• Lambert E., Dasse E., Haye B, Petitfrere E. TIMPs as multifacial proteins. Crit. Rev. Oncol. Hematol. 2004; 49: 187–198
   PubMed Web of Science ®Google Scholar
• Lee K. S., Buck M., Houghum K., Chojkier M. Activation of hepatic stellate cells by TGF-alpha and collagen type I is mediated by oxidative stress through c-myc expression. J. Clin Invest. 1995; 96: 2461–2468
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosebrough M. J., Farr L., Randell R. J. Protein measurement with the folin-phenol reagent. J. Biol. Chem. 1951; 93: 464–478
   Google Scholar
• Masamune A., Satoh M., Kikuta K., Suzuki N., Satoh K., Shimosegawa T. Ellagic acid blocks activation of pancreatic stellate cells. Biochem. Pharmacol. 2005; 70: 869–878
   PubMed Web of Science ®Google Scholar
• McLaughlim B., Cawston T., Weiss J. B. Activation of the matrix metalloproteinase inhibitor complex by a low molecular weight angiogenic factor. Biochim. Biophys. Acta 1991; 1073: 295–298
   Google Scholar
• Milani S., Herbst H., Schuppan D., Grappone C., Pellegrini G., Prinzani M., Casini A., Calabru A., Ciancio G., Stefanini F., Burroughs A. K., Surrenti C. Differential expression of matrix-metalloproteinase-1 & -2 genes in normal and fibrotic human liver. Am. J. Pathol. 1994; 144: 528–537
   PubMed Web of Science ®Google Scholar
• Nagase H. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 1997; 378: 151–160
   PubMed Web of Science ®Google Scholar
• Nagase H., Visse R., Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovas. Res. 2006; 69: 562–573
   PubMed Web of Science ®Google Scholar
• Nagase H., Woessner J. F. Matrix metalloproteinase. J. Biol. Chem. 1999; 274: 21491–21494
   PubMed Web of Science ®Google Scholar
• Niemela O., Parkkila S., Yla-Herttuala S., Villanueva J., Ruebner B., Halsted C. H. Sequential acetaldehyde production, lipid peroxidation and fibrogenesis in micropig model of alcohol-induced liver disease. Hepatology 1995; 22: 1208–1214
   PubMed Web of Science ®Google Scholar
• Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol. Aspects Med. 2000; 21: 49–98
   PubMedGoogle Scholar
• Priyadarsini K. I., Khopde S. M., Kumar S. S., Mohan H. Free radical studies of ellagic acid, a natural phenolic antioxidant. J. Agric. Food Chem. 2002; 50: 2200–2206
   PubMed Web of Science ®Google Scholar
• Rajakrishnan V., Viswanathan P., Menon V. P. Hepatotoxic effect of alcohol on female rats and siblings: effects of n-acetyl cysteine. Hepatol. Res. 1997; 9: 37–50
   Web of Science ®Google Scholar
• Rao S. K., Mathrubutham M., Karteron A., Sorensen K., Cohen J. R. A versatile microassay for elastase using succinylated elastin. Anal. Biochem. 1997; 250: 222–227
   Google Scholar
• Sluijter J. P., de Kleijn D. P., Pasterkamp G. Vascular remodeling and protease inhibition-bench to bed side. Cardiovasc. Res. 2006; 69: 595–603
   PubMed Web of Science ®Google Scholar
• Siwik D. A., Colucci W. S. Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. Heart Fail. Rev. 2004; 9: 43–51
   Google Scholar
• Talcott S. T., Lee J. H. Ellagic acid and flavonoid antioxidant content of muscadine wine and juice. J. Agric. Food Chem. 2002; 50: 3186–3192
   PubMed Web of Science ®Google Scholar
• Thresiamma K. C., Kuttan R. Inhibition of liver fibrosis by ellagic acid. Indian J. Physiol. Pharmacol. 1996; 40: 363–366
   PubMedGoogle Scholar
• Wilson T., Lewis M. J., Cha K. L., Gold B. Effect of ellagic acid on xenobiotic metabolism by cytochrome P-450IIE1 and nitrosodimethylamine mutagenicity. Cancer Lett. 1992; 61: 129–134
   PubMed Web of Science ®Google Scholar
• Xu Y. M., Deng J. Z., Ma J., Chen S. N., Marshall R., Jones S. H., Johnson R. K., Hecht S. M. DNA damaging activity of ellagic acid derivatives. Bioorg. Med. Chem. 2003; 11: 1593–1596
   PubMedGoogle Scholar
• Zhang X., Azhar G., Nagano K., Wie J. Y. Differential vulnerability to oxidative stress in rat cardiac myocytes versus fibroblasts. J. Am. Coll. Cardiol. 2001; 38: 2055–2062
   Google Scholar